Guggenheim Boosts Verastem (NASDAQ:VSTM) Price Target to $14.00
Verastem (NASDAQ:VSTM – Get Free Report) had its price target increased by equities researchers at Guggenheim from $13.00 to $14.00 in a report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Guggenheim’s price target would indicate a potential upside of 113.09% from the stock’s previous close. A […]
Verastem (NASDAQ:VSTM – Get Free Report) had its price target increased by equities researchers at Guggenheim from $13.00 to $14.00 in a report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Guggenheim’s price target would indicate a potential upside of 113.09% from the stock’s previous close. A […]
